XML 87 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
SHARE-BASED PAYMENTS
12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Payments
SHARE-BASED PAYMENTS
The Company, under the 2015 Omnibus Equity Incentive Compensation Plan (the “Compensation Plan”), maintains a stock incentive plan for directors, executives, eligible employees and consultants. Stock incentive awards include employee stock options and restricted stock units (“RSUs”). The Company issues new shares of common stock to satisfy exercises and vesting under all of its stock incentive awards. At December 31, 2016, a total of 6,620,515 common shares were authorized for stock incentive plan awards.
Employee Stock Options
The Company, under the Compensation Plan may grant options to directors, executives, employees and consultants to purchase common shares of the Company. The exercise price of the options is set as the higher of the Company’s closing share price on the day before the grant date or the five-day volume weighted average price. Stock options granted under the Compensation Plan generally vest over a period of two years or more and are generally exercisable over a period of five years from the grant date not to exceed 10 years. The value of each option award is estimated at the grant date using the Black-Scholes Option Valuation Model. There were 0.45 million options granted in the year ended December 31, 2016 (December 31, 20152.17 million, December 31, 2014 - 307,250). At December 31, 2016, there were 2.15 million options outstanding with 1.82 million options exercisable, at a weighted average exercise price of $5.69, with a weighted average remaining contractual life of 3.58 years. The aggregate intrinsic value of the fully vested shares was $nil.
The summary of the Company’s stock options at December 31, 2016, 2015 and 2014, and the changes for the fiscal periods ending on those dates is presented below:
 
Range of Exercise Prices
$
 
Weighted Average
Exercise Price
$
 
Number of
Options
 
Balance, January 1, 2014
 7.60 - 44.22
 
14.27
 
795,318
 Granted
9.05
 
9.05
 
307,250
 Exercised
8.75
 
8.75
 
(15,000)
 Forfeited
7.60 - 44.22
 
14.70
 
(158,655)
 Expired
17.50
 
17.50
 
(23,500)
Balance, December 31, 2014
 7.60 - 44.22
 
11.66
 
905,413
 Granted
2.55 - 18.55
 
6.02
 
2,176,330
 Exercised
2.55 - 4.48
 
3.78
 
(48,802)
 Forfeited
4.44 - 29.71
 
7.29
 
(574,486)
 Expired
7.47 - 32.10
 
7.42
 
(335,558)
Balance, December 31, 2015
 2.55 - 32.10
 
6.54
 
2,122,897
 Granted
2.12 - 2.22
 
2.13
 
449,537
 Exercised
2.12
 
2.12
 
(8,369)
 Forfeited
2.12 - 18.99
 
5.52
 
(317,960)
 Expired
2.95 - 32.03
 
8.03
 
(200,962)
Balance, December 31, 2016
 2.12 - 15.61
 
5.69
 
2,045,143

As of December 31, 2016, the outstanding stock options denominated in Cdn$ were as follows:
 
Options outstanding
 
Options exercisable
Exercise price
(Cdn$)
Quantity
 
Weighted average price
($Cdn)
 
Weighted average remaining contractual life
 
Intrinsic Value
 
Quantity
 
Weighted average price
($Cdn)
 
Weighted average remaining contractual life
 
Intrinsic Value
$0.00 to $4.99

 
$

 
0.00
 
$

 

 
$

 
0.00
 
$

$5.00 to $9.99
421,850

 
6.55

 
1.37
 

 
395,100

 
6.99

 
1.46
 

$10.00 to $14.99
171,370

 
11.50

 
0.64
 

 
171,370

 
11.50

 
0.64
 

$15.00 to $19.99
62,900

 
$
15.50

 
0.18
 

 
62,900

 
$
15.50

 
0.18
 

 
656,120

 
 
 
 
 
$

 
629,370

 
 
 
 
 
$


As of December 31, 2016, the outstanding stock options denominated in USD$ were as follows:
 
Options outstanding
 
Options exercisable
Exercise price
($)
Quantity
 
Weighted average price
($)
 
Weighted average remaining contractual life
 
Intrinsic Value
 
Quantity
 
Weighted average price
($)
 
Weighted average remaining contractual life
 
Intrinsic Value
$0.00 to $4.99
876,987

 
$
3.47

 
5.35
 
$

 
676,559

 
$
3.80

 
5.76
 
$

$5.00 to $9.99
370,512

 
6.13

 
3.70
 

 
370,512

 
6.13

 
3.70
 

$10.00 to $14.99
127,499

 
10.68

 
1.22
 

 
127,499

 
10.68

 
1.22
 

$15.00 to $19.99
14,025

 
$
15.61

 
4.02
 

 
14,025

 
$
15.61

 
4.02
 

 
1,389,023

 
 
 
 
 
$

 
1,188,595

 
 
 
 
 
$



In the years ended December 31, 2016 the Company issued 8,369 shares upon exercise of stock options at an average exercise price of $2.12 for proceeds of less than $0.02 million. These options had an intrinsic value of less than $0.01 million.
In the year ended December 31, 2015 the Company issued 48,802 shares upon exercise of stock options at an average exercise price of $3.87 for proceeds of $0.18 million. These options had an intrinsic value of $0.06 million.
In the year ended December 31, 2014 the Company issued 15,000 shares upon exercise of stock options at an average exercise price of $7.97 (Cdn$8.75) for proceeds of $0.12 million. These options had an intrinsic value of $0.02 million.
The share-based compensation recorded during the years ended months ended December 31, 2016, 2015 and 2014 is as follows:
 
Years ended
 
December 31,
 
2016
 
2015
 
2014
Share-based compensation (1)(2)
$
2,657

 
$
1,099

 
$
1,405

Replacement of options from business combinations and asset acquisitions (3)

 
3,681

 

Value of stock options and RSUs granted
$
2,657

 
$
4,780

 
$
1,405


(1)
The fair value of the options granted under the Compensation Plan for the years ended December 31, 2016, 2015 and 2014, was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted-average assumptions:

2016
 
2015
 
2014
Risk-free interest rate
1.03% - 1.43%

 
0.87
%
 
1.6
%
Expected life
5.0 years

 
5.0 years

 
5.0 years

Expected volatility
64.7% -74.8%*

 
75.1%*

 
81%*

Expected dividend yield
0
%
 
0
%
 
0
%
Weighted-average expected life of option
5.00

 
4.99

 
5.00

Weighted-average grant date fair value
$1.22 - $1.23

 
2.64

 
5.27

*
Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the options.

(2)
The fair value of the RSUs granted under the Compensation Plan for the years ended December 31, 2016, 2015 and 2014, was estimated at the date of grant, using the stated market price.

(3)
During business combinations and asset acquisitions the Company may issue options to replace options of the acquired companies. For the year ended December 31, 2015, the fair value of stock options granted to employees, directors and consultants of companies acquired through business combinations and asset acquisitions was estimated on the closing date of the transaction using the Black-Scholes option pricing model with the following assumptions:

 
 
Risk-free interest rate
0.0% to 2.35%

Expected life
0.05 years to 10 years

Expected volatility
18.47 to 93.31%*

Expected dividend yield
0
%
Weighted-average expected life of option
4.52

Weighted-average grant date fair value
$1.89
*
Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the options.

A summary of the status and activity of non-vested stock options at December 31, 2016 is as follows:
 
Number of shares
 
Weighted Average Grant- Date Fair Value
Non-vested January 1, 2014

 
$

 Granted
307,250

 
5.27

 Vested
(153,625
)
 
5.27

 Forfeited
(14,025
)
 
5.27

Non-vested December 31, 2014
139,600

 
5.27

 Granted
2,176,330

 
1.93

 Vested
(2,119,803
)
 
2.00

 Forfeited
(18,429
)
 
5.17

Non-vested December 31, 2015
177,698

 
3.44

 Granted
449,537

 
1.29

 Vested
(331,482
)
 
2.26

 Forfeited
(68,575
)
 
1.56

Non-vested December 31, 2016
227,178

 
$
1.48


Restricted Stock Units
The Company grants RSUs to executives and eligible employees. Awards are determined as a target percentage of base salary and vest over periods of three years. Prior to vesting, holders of restricted stock units do not have the right to vote the underlying shares. The restricted stock units are subject to forfeiture risk and other restrictions. Upon vesting, the employee is entitled to receive one share of the Company’s common stock for each restricted stock unit for no additional payment. During the year ended December 31, 2016, the Company’s Board of Directors approved the issuance of 1.21 million RSUs under the Compensation Plan (20150.27 million).
A summary of the status and activity of non-vested RSUs at December 31, 2016 is as follows:
 
Number of shares
 
Weighted Average Grant- Date Fair Value
Non-vested January 1, 2014

 
$

 Granted

 

 Vested

 

 Forfeited

 

Non-vested December 31, 2014

 

 Granted
282,716

 
4.05

 Vested

 

 Forfeited
(9,850
)
 
4.68

Non-vested December 31, 2015
272,866

 
4.03

 Granted
1,205,336

 
2.14

 Vested
(138,608
)
 
4.65

 Forfeited
(9,125
)
 
5.39

Non-vested December 31, 2016
1,330,469

 
$
2.37


The total fair value of RSUs that vested and were settled for equity in the year ended December 31, 2016 was $0.30 million (2015$nil, 2014- $nil).
At December 31, 2016, there was $0.08 million and $0.84 million of unrecognized compensation costs related to the unvested stock options and RSU awards, respectively. This cost is expected to be recognized over a period of approximately three years.